ArticleOncoTargets and therapy2019

MiR-145 inhibits EGF-induced epithelial-to-mesenchymal transition via targeting Smad2 in human glioblastoma.

Weijie Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.